GoodRx Holdings (GDRX) Operating Leases (2019 - 2026)

GoodRx Holdings has disclosed Operating Leases across 8 years of filings, most recently posting $47.0 million for Q2 2026.

• In Q2 2026, Operating Leases fell 10.88% year-over-year to $47.0 million; the TTM figure through Jun 2026 stood at $47.0 million (down 10.88% YoY), while the FY2025 annual figure was $49.8 million, up 8.14% from the prior year.
• Operating Leases came in at $47.0 million for Q2 2026 at GoodRx Holdings, down from $49.0 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $56.3 million in Q1 2023 to a low of $32.5 million in Q1 2022.
• Average Operating Leases over 5 years is $47.4 million, with a median of $49.1 million recorded in 2024.
• Year-over-year, Operating Leases soared 73.1% in 2023 and dropped 12.75% in 2025.
• Over 5 years, Operating Leases stood at $54.1 million in 2022, then slipped by 10.58% to $48.4 million in 2023, then slipped by 4.88% to $46.0 million in 2024, then gained by 8.14% to $49.8 million in 2025, then decreased by 5.59% to $47.0 million in 2026.
• Per Business Quant data, the three most recent Operating Leases figures were $47.0 million in Q2 2026, $49.0 million in Q1 2026, and $49.8 million in Q4 2025.